Related Experiment Video
Updated: Mar 22, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry
Shuoyan Ning1, Rebecca Barty1, Yang Liu1
1Department of Medicine, Division of Hematology and Thromboembolism, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Platelet transfusions are often given in the ICU, but one in five are ineffective. Addressing ABO incompatibility can improve platelet transfusion quality and reduce overuse.
Area of Science:
- Critical Care Medicine
- Hematology
- Transfusion Medicine
Background:
- Platelet transfusions are a common intervention for critically ill patients.
- However, optimal transfusion thresholds, expected platelet count increments, and predictors of ineffective transfusions remain poorly understood.
Purpose of the Study:
- To identify predictors of ineffectual platelet transfusions in intensive care unit (ICU) patients.
- To analyze transfusion practices and outcomes in a large cohort of critically ill patients.
Main Methods:
- A retrospective study analyzed data from 7,320 ICU admissions involving 15,879 platelet transfusions across three Canadian academic hospitals (2006-2015).
- Ineffectual transfusions were defined as those increasing platelet counts by less than 5 × 10(9)/L.
- Predictors of ineffectual transfusions and reasons for transfusion despite normal platelet counts were evaluated.
Main Results:
- The median pretransfusion platelet count was 87 × 10(9)/L, with 79.6% of transfusions given when counts were ≥ 50 × 10(9)/L.
- The median platelet count increment was 23 × 10(9)/L, and 21.8% of transfusions were ineffectual.
- ABO incompatibility, sepsis, liver disease, and concurrent red cell/cryoprecipitate transfusions were associated with poor platelet count increments.
Conclusions:
- Platelet transfusions are frequently administered in ICUs, often at higher pretransfusion counts (≥ 50 × 10(9)/L).
- A significant proportion (21.8%) of transfusions resulted in minimal platelet count increase, indicating ineffectual outcomes.
- Identifying modifiable factors like ABO incompatibility can guide strategies to optimize platelet transfusion efficacy and reduce unnecessary use.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Continuous Renal Replacement Therapy
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Venous Thrombosis III: Interprofessional Care

